Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts

Citation
Gh. Ring et al., Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts, TRANSPLANT, 67(10), 1999, pp. 1362-1365
Citations number
17
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
TRANSPLANTATION
ISSN journal
00411337 → ACNP
Volume
67
Issue
10
Year of publication
1999
Pages
1362 - 1365
Database
ISI
SICI code
0041-1337(19990527)67:10<1362:IINFIT>2.0.ZU;2-5
Abstract
Background. Although interferon (IFN)gamma has immunostimulatory functions, it is not essential for the acute rejection of fully allogeneic grafts in mice. It is not known whether IFN gamma plays a critical role in the acute rejection of MHC class I- or MHC class II-disparate allografts. Methods. We studied the survival of skin allografts transplanted from fully allogeneic (BALB/c), MHC class I-disparate (bm1), or MHC class ZI-disparat e (bm12) donors to C57BL/6 wild-type (IFN gamma(+/+)) and IFN gamma gene-kn ockout (IFN gamma(+/+)) recipients. We also investigated the in vitro respo nses of IBN gamma(+/+) and IFN gamma(-/-) T cells to MHC class II-disparate splenocytes. Results. We found that IFN gamma(-/-) recipients reject BALB/c and bm1 skin grafts at the same rate as IFN gamma(+/+) mice but are not capable of reje cting bm12 skin. Despite the inability of IFN gamma(-/-) mice to reject bm1 2 skin grafts, IFN gamma(-/-) T cells displayed vigorous proliferation and cytotoxic responses when stimulated with bm12 splenocytes in vitro. Further more, priming IFN gamma(-/-) recipients with bm12 splenocytes enabled these mice to reject bm12 skin grafts at a normal rate and to mount a cutaneous delayed-type hypersensitivity response to the bm12 antigen. Conclusion. The data demonstrate that IFN gamma is not necessary for genera ting effector mechanisms associated with acute transplant rejection but tha t it is required for initiating alloimmune responses to MHC class II dispar ate skin grafts.